Subramanian S, Das Majumdar S, Biswas G, Joshi N, Bunger D, Khan M
Mol Clin Oncol. 2020; 13(3):14.
PMID: 32754328
PMC: 7391841.
DOI: 10.3892/mco.2020.2084.
Zurlo I, Basso M, Strippoli A, Calegari M, Orlandi A, Cassano A
Cancers (Basel). 2020; 12(7).
PMID: 32630186
PMC: 7409310.
DOI: 10.3390/cancers12071749.
Jiang Z, Sun Y, Zhang W, Cui C, Yang L, Zhou A
Asia Pac J Clin Oncol. 2020; 16(3):180-186.
PMID: 32077628
PMC: 7318315.
DOI: 10.1111/ajco.13321.
Wang X, Zeng Z, Ye X, Sun J, Zhang Z, Kang W
World J Gastrointest Oncol. 2020; 12(1):37-53.
PMID: 31966912
PMC: 6960069.
DOI: 10.4251/wjgo.v12.i1.37.
Cheng J, Cai M, Shuai X, Gao J, Wang G, Tao K
Ther Adv Med Oncol. 2019; 11:1758835919838963.
PMID: 31044021
PMC: 6446435.
DOI: 10.1177/1758835919838963.
Impact of duration of adjuvant chemotherapy in radically resected patients with T4bN1-3M0/TxN3bM0 gastric cancer.
Wang Q, Zhang X, Lu M, Shen L
World J Gastrointest Oncol. 2018; 10(1):31-39.
PMID: 29375746
PMC: 5767791.
DOI: 10.4251/wjgo.v10.i1.31.
Lymph node ratio-based staging system as an alternative to the current TNM staging system to assess outcome in adenocarcinoma of the esophagogastric junction after surgical resection.
Zhang H, Shang X, Chen C, Gao Y, Xiao X, Tang P
Oncotarget. 2016; 7(45):74337-74349.
PMID: 27517157
PMC: 5342057.
DOI: 10.18632/oncotarget.11188.
National Trends in Utilization of Endoscopic Ultrasound for Gastric Cancer: a SEER-Medicare Study.
Huntington C, Walsh K, Han Y, Salo J, Hill J
J Gastrointest Surg. 2015; 20(1):154-63.
PMID: 26553265
DOI: 10.1007/s11605-015-2988-8.
Multimodality management of resectable gastric cancer: A review.
Shum H, Rajdev L
World J Gastrointest Oncol. 2014; 6(10):393-402.
PMID: 25320655
PMC: 4197430.
DOI: 10.4251/wjgo.v6.i10.393.
Prognosis of patients with gastric cancer and solitary lymph node metastasis.
Chen C, Wu X, Yu Z, Bu Z, Zuo K, Li Z
World J Gastroenterol. 2014; 19(46):8611-8.
PMID: 24379578
PMC: 3870506.
DOI: 10.3748/wjg.v19.i46.8611.
Nano-curcumin inhibits proliferation of esophageal adenocarcinoma cells and enhances the T cell mediated immune response.
Milano F, Mari L, van de Luijtgaarden W, Parikh K, Calpe S, Krishnadath K
Front Oncol. 2013; 3:137.
PMID: 23755374
PMC: 3665944.
DOI: 10.3389/fonc.2013.00137.
Refining docetaxel-containing therapy for gastric cancer.
Khokhar N, Jiang Y, Benson 3rd A, Ajani J, Mulcahy M
Gastrointest Cancer Res. 2011; 4(3):96-105.
PMID: 22043325
PMC: 3201643.
Detection of lymph node involvement by cytokeratin immunohistochemistry is an independent prognostic factor after curative resection of esophageal cancer.
Marjanovic G, Schricker M, Walch A, Zur Hausen A, Hopt U, Imdahl A
J Gastrointest Surg. 2010; 15(1):29-37.
PMID: 20976569
DOI: 10.1007/s11605-010-1359-8.
Neoadjuvant treatment of esophageal cancer.
Campbell N, Villaflor V
World J Gastroenterol. 2010; 16(30):3793-803.
PMID: 20698042
PMC: 2921091.
DOI: 10.3748/wjg.v16.i30.3793.
Prognostic impact of metastatic lymph node ratio in advanced gastric cancer from cardia and fundus.
Huang C, Lin B, Lu H, Zhang X, Li P, Xie J
World J Gastroenterol. 2008; 14(27):4383-8.
PMID: 18666330
PMC: 2731193.
DOI: 10.3748/wjg.14.4383.
Effect of lymphadenectomy extent on advanced gastric cancer located in the cardia and fundus.
Huang C, Lin B, Lu H, Zhang X, Li P, Xie J
World J Gastroenterol. 2008; 14(26):4216-21.
PMID: 18636669
PMC: 2725385.
DOI: 10.3748/wjg.14.4216.